Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pentoxifylline for Vascular Cognitive Impairment (Single-center RCT)
ChiCTR2500104470Phase 4Not yet recruiting
- Sponsor
- Wenzhou People's Hospital
- Start
- Jun 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of pentoxifylline in vascular cognitive disorder (VCD) (2 arms), sponsored by Wenzhou People's Hospital. Primary endpoint: MMSE score change from baseline at Day 180. Planned start Jun 2025; status: not yet recruiting.
02
Drugs
pentoxifylline
03
Conditions
vascular cognitive disorder (VCD)
Beyond the preview
Go deeper on ChiCTR2500104470.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2500104470.